Anthropic acquired Mithril Medicine, a one-person biotechnology company developing therapies for two rare forms of muscular dystrophy

Drug pricing and affordability, FDA drug approvals, clinical trial design, drug shortages, insurer coverage, pharmaceutical regulation, and medication access.